Magnolol; 528-43-8; 5,5'-Diallyl-[1,1'-biphenyl]-2,2'-diol; 5,5'-Diallyl-2,2'-biphenyldiol; 2,2'-Bichavicol; 5,5'-Diallyl-2,2'-dihydroxybiphenyl; Dehydrodichavicol; NSC 293099; 2-(2-hydroxy-5-prop-2-enylphenyl)-4-prop-2-enylphenol; 4-allyl-2-(5-allyl-2-hydroxy-phenyl)phenol; MFCD00016658; MLS001048917; 001E35HGVF; CHEBI:6643; 5,5'-di(prop-2-en-1-yl)biphenyl-2,2'-diol; 2-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-1-yl)phenol; 5,5'-Diallylbiphenyl-2,2'-diol; [1,1'-Biphenyl]-2,2'-diol, 5,5'-di-2-propenyl-; NSC-293099; SMR000387108; (1,1'-Biphenyl)-2,2'-diol, 5,5'-di-2-propenyl-; 2'-Bichavicol; SR-01000758206; UNII-001E35HGVF; Kopnolia; HSDB 7686; Magnolol,(S); MAGNOLOL [HSDB]; MAGNOLOL [INCI]; MAGNOLOL [MI]; UPCMLD-DP037; cid_72300; SCHEMBL132477; REGID_for_CID_72300; CHEMBL180920; ZINC1645; DTXSID0044076; FEMA NO. 4559; UPCMLD-DP037:001; BDBM78304; HMS2269N09; HMS3651O18; AMY40661; BCP28276; HY-N0163; AC-931; BBL027818; NSC293099; s2321; STK801955; AKOS005266409; CCG-208588; CS-5021; DS-1284; SMP2_000086; Magnolol, >=95% (HPLC), from plant; NCGC00161609-01; NCGC00161609-02; SY016075; D3971; FT-0628104; SW219728-1; 2,2'-DIHYDROXY-5,5'-DIALLYLBIPHENYL; EN300-7368364; A829277; 5,5'-Di-2-propenyl-[1,1'-biphenyl]-2,2'-diol; Q-100598; Q6732002; SR-01000758206-3; SR-01000758206-4; BRD-K26168087-001-01-4; Magnolol, European Pharmacopoeia (EP) Reference Standard; Z1741977128; [1,1'-Biphenyl]-2,2'-diol, 5,5'-di-2-propen-1-yl-; 2-(2-oxidanyl-5-prop-2-enyl-phenyl)-4-prop-2-enyl-phenol; 5,5'-bis(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol; 5,5'-DI-2-PROPEN-1-YL-(1,1'-BIPHENYL)-2,2'-DIOL; 5,5 inverted exclamation mark -Diallyl-2,2 inverted exclamation mark -biphenyldiol